ISP

Recommendations in DME Management - Diagnosis, Monitoring, and Treatment

Prof John Kitchens

Dr. John Kitchens, a retina specialist, discussed diabetic macular oedema (DME) and its management in this video. Diagnosis of DME relies on fluorescein angiography (FA) and OCT imaging, with monthly monitoring recommended during active disease. Treatment options include anti-VEGF therapy as the first-line standard of care, offering the best outcomes, especially with aflibercept for patients with lower visual acuity (<69 letters). Corticosteroids and surgery are considered secondary options. The guidance incorporates evidence from international expert groups, which highlighted intensive treatment strategies to improve patient outcomes.

Related content

Professor Andrew Chang: Aflibercept in DME
PP-EYL-IN-0236-1, September 2024
Protocol T Infographic Video
Video on Comparative Effectiveness of anti-VEGFs for Diabetic Macular Edema (DME) Protocol T.
PP-EYL-IN-0268-1, September 2024
Prof. Daniel Barthlmes: Eylea RWE
PP-EYL-IN-0239-1, September 2024